Skip navigation
Speakers

Achieve Excellence in Management of GTN Processes, Accounting, Forecasting Accuracy and Profitability

June 14, 2018
  • San Francisco, CA

Eric Benson
Audit and Assurance Senior
Deloitte & Touche LLP

Larry Breen
Director, Financial Planning and Analysis / Revenue Analytics
Sunovion Phamaceuticals

Cheryl Collett
Vice President, Finance and Accounting
Puma Biotechnology, Inc.

Brittany Honeycutt
Manager
Deloitte & Touche LLP

Murray Kay
former Senior Vice President & CFO, Solvay Pharmaceuticals;
Commercial Controller, AbbVie & Abbott Laboratories

David Lowrance
Chief Financial Officer
Savara

Mike Makovec
Senior Manager
Deloitte & Touche LLP

Jeff Pelger
Senior Director, Commercial Financial Planning and Analysis
Gilead Sciences

Brad Schulte
Senior Manager
Deloitte & Touche LLP

Jennifer Sharpe
Senior Director, Revenue Analytics Collaborative
daVIZta Inc., a Revenue Analytics Company

Amine Sinmazisik
Director, Accounting and Reporting
Eagle Pharmaceuticals

Alex Smith
Partner
Deloitte & Touche LLP

Joe Warchol
Executive Director, US Business Operations Finance
Amgen

Eric Benson
Audit and Assurance Senior
Deloitte & Touche LLP

Larry Breen
Director, Financial Planning and Analysis / Revenue Analytics
Sunovion Phamaceuticals

Cheryl Collett
Vice President, Finance and Accounting
Puma Biotechnology, Inc.

Brittany Honeycutt
Manager
Deloitte & Touche LLP

Murray Kay
former Senior Vice President & CFO, Solvay Pharmaceuticals;
Commercial Controller, AbbVie & Abbott Laboratories

David Lowrance
Chief Financial Officer
Savara

Mike Makovec
Senior Manager
Deloitte & Touche LLP

Jeff Pelger
Senior Director, Commercial Financial Planning and Analysis
Gilead Sciences

Brad Schulte
Senior Manager
Deloitte & Touche LLP

Jennifer Sharpe
Senior Director, Revenue Analytics Collaborative
daVIZta Inc., a Revenue Analytics Company

Amine Sinmazisik
Director, Accounting and Reporting
Eagle Pharmaceuticals

Alex Smith
Partner
Deloitte & Touche LLP

Joe Warchol
Executive Director, US Business Operations Finance
Amgen